Avid Bioservices, Inc. (CDMO) Financials
CDMO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-10-31 | 454.6 million | 271.0 million |
2023-07-31 | 442.3 million | 251.7 million |
2023-04-30 | 451.1 million | 261.6 million |
2023-01-31 | 450.4 million | 265.0 million |
CDMO Free Cash Flow and Stock based compensation
No data available :(
CDMO Net Income
No data available :(
CDMO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-10-31 | 31.4 million | - | 54.1 million |
2023-07-31 | 24.9 million | - | 48.1 million |
2023-04-30 | 38.5 million | 140.6 million | 48.6 million |
2023-01-31 | 59.9 million | 140.4 million | 40.4 million |
CDMO Shares Outstanding
CDMO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-10-31 | 7.3 million | - | 6.6 million | - |
2023-07-31 | 14.1 million | - | 6.3 million | - |
2023-04-30 | 24.9 million | - | 6.9 million | 700000 |
2023-01-31 | 11.3 million | - | 7.1 million | - |
CDMO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-10-31 | 25.4 million | 30.1 million |
2023-07-31 | 37.7 million | 33.6 million |
2023-04-30 | 39.8 million | 31.4 million |
2023-01-31 | 38.0 million | 28.2 million |
CDMO
Price: $7.67
52 week price:
Earnings Per Share: -0.18 USD
P/E Ratio: -36.78
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 451500
Ebitda: -12.0 millionMarket Capitalization: 436.4 million